- Benefits of Recurrent Colonic Stent Insertion in a Patient with Advanced Gastric Cancer with Carcinomatosis Causing Colonic Obstruction
-
Park S, Shin SJ, Ahn JB, Jeung HC, Rha SY, Lee SK, Chung HC
- KMID: 2396077
- Yonsei Med J.
- 2009 Apr;50(2):296-299.
Malignant obstruction develops frequently in advanced gastric cancer. Although it is primarily the gastric outlet that is obstructed, there are occasional reports of colonic obstruction. Treating intestinal obstruction usually requires... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of toxoplasmosis mimicking systemic recurrence in a patient treated with breast cancer
-
Kim BK, Cho BC, Lee YW, Chung HS, Jeung HC, Rha SY, Chung HC
- KMID: 2256669
- Korean J Med.
- 2006 Jul;71(1):108-113.
Left cervical lymphadenopathy was found in a 48-year-old Korean female patient who had been treated for breast cancer 3 years ago. A presumative diagnosis was lymph nodal and lung metastasis... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Survival after Surgical Resection for Liver Metastasis from Gastric Cancer: Two Case Reports
-
Lim JK, Ahn JB, Cheon SH, Chang H, Jung JY, Rha SY, Roh JK, Noh SH, Kim HG, Chung HC, Jeung HC
- KMID: 2166064
- Cancer Res Treat.
- 2006 Jun;38(3):184-188.
Surgical resection of colorectal cancer metastasis to the liver results in a 5-year survival rate of around 40%. Liver metastasis from other cancers such as neuroendocrine carcinoma and genitourinary tumors... -
- CITED
-
- Close
- SHARE
-
- Close
- Significant Gene Selection Using Integrated Microarray Data Set with Batch Effect
-
Kim KY, Chung HC, Jeung HC, Shin JH, Kim TS, Rha SY
- KMID: 1512145
- Genomics Inform.
- 2006 Sep;4(3):110-117.
In microarray technology, many diverse experimental features can cause biases including RNA sources, microarray production or different platforms, diverse sample processing and various experiment protocols. These systematic effects cause a... -
- CITED
-
- Close
- SHARE
-
- Close
- A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and Taxane-based Neoadjuvant Chemotherapy: A Case Report
-
Kim SH, Chung HC, Jeong J, Kim JH, Rha SY, Ahn JB, Cho NH, Jeung HC
- KMID: 1522937
- Cancer Res Treat.
- 2007 Sep;39(3):134-137.
Atypical medullary carcinomas and carcinosarcoma have unique histopathological features. Here we present a case with a breast malignancy that had pathological characteristics of both. A 54-year old patient with a... -
- CITED
-
- Close
- SHARE
-
- Close
- Immune-related Adverse Events: Overview and Management Strategies for the Use of Immune Checkpoint Inhibitors
-
Jeung HC, Oh SE, Kim JH
- KMID: 2459447
- J Rheum Dis.
- 2019 Oct;26(4):221-234.
- doi: 10.4078/jrd.2019.26.4.221
Recent studies on T cell immunology have been instrumental in developing therapies to overcome cancer immune escape, and immune checkpoint inhibitors have emerged as one of the most promising therapeutic... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy in Cancer Patients with Comorbidity
-
Jeung HC, Moon YW
- KMID: 2333542
- J Korean Gastric Cancer Assoc.
- 2004 Jun;4(2):59-74.
This report attempts to explain the (i) implications of comorbidity for research and practice in the fieldo of oncology, (ii) the approach for dosing of anti-cancer drugs in the presence... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent advance in tailored treatment of gastric cancer
-
Jeung HC, Rha SY
- KMID: 2305795
- Korean J Med.
- 2009 Jul;77(1):1-8.
Even the overall incidence is decreasing and the proportion of early gastric cancer is increasing from the national mass screening program, still gastric cancer is the major issue in Korea.... -
- CITED
-
- Close
- SHARE
-
- Close
- S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
-
Jung JY, Rha SY, Ahn JB, Yang WI, Noh SH, Chung HC, Jeung HC
- KMID: 1382660
- Korean J Intern Med.
- 2008 Mar;23(1):37-41.
- doi: 10.3904/kjim.2008.23.1.37
S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1... -
- CITED
-
- Close
- SHARE
-
- Close
- An Attempt for Combining Microarray Data Sets by Adjusting Gene Expressions
-
Kim KY, Kim SH, Ki DH, Jeong J, Jeong HJ, Jeung HC, Chung HC, Rha SY
- KMID: 2166100
- Cancer Res Treat.
- 2007 Jun;39(2):74-81.
PURPOSE: The diverse experimental environments in microarray technology, such as the different platforms or different RNA sources, can cause biases in the analysis of multiple microarrays. These systematic effects present... -
- CITED
-
- Close
- SHARE
-
- Close
- Leptomeningeal Carcinomatosis in Solid Tumors; Clinical Manifestation and Treatment
-
Park JO, Shin HJ, Kim HJ, Lee SW, Jeung HC, Kim SM, Yoo NC, Chung HC, Kim JH, Kim BS, Min JS, Roh JK
- KMID: 2007124
- J Korean Cancer Assoc.
- 2001 Feb;33(1):34-40.
PURPOSE: Leptomeningeal carcinomatosis occurs in about 5% of patients with solid tumor and is being diagnosed with increasing frequency as patients live longer and as neuro-imaging studies improve. In general,... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Pre- and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities
-
Sohn JH, Rha SY, Jeung HC, Shin HJ, Goo YS, Chung HC, Yang WI, Hahn SB, Shin KH, Min JS, Kim BS, Roh JK, Jang WI
- KMID: 2166227
- Cancer Res Treat.
- 2001 Dec;33(6):520-526.
PURPOSE: We evaluated the treatment efficacy including survival and recurrence, and factors associated with recurrence in osteosarcoma patients treated with preoperative chemotherapy, surgery, and adjuvant chemotherapy. MATERIALS AND METHODS: Forty nine... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognosis of pN3 Stage Gastric Cancer
-
Ahn JR, Jung M, Kim C, Hong MH, Chon HJ, Kim HR, Jeung HC, Hyung WJ, Lee SS, Chung HC, Noh SH, Rha SY
- KMID: 2165982
- Cancer Res Treat.
- 2009 Jun;41(2):73-79.
PURPOSE: The aim of this study was to determine the prognosis of pN3 stage gastric cancer patients after they have undergone curative resection, and we also wanted to identify the... -
- CITED
-
- Close
- SHARE
-
- Close
- Docetaxel versus Paclitaxel Combined with 5-FU and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials
-
Chon HJ, Rha SY, Im CK, Kim C, Hong MH, Kim HR, An JR, Noh SH, Chung HC, Jeung HC
- KMID: 1972672
- Cancer Res Treat.
- 2009 Dec;41(4):196-204.
PURPOSE: This is an ad hoc analysis of two phase II studies which compared the efficacy and safety of two taxanes (paclitaxel and docetaxel) combined with 5-fluorouracil (5-FU) and leucovorin... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
-
Kim GM, Jeung HC, Kim D, Kim JH, Yoon SH, Jung ES, Shin SJ
- KMID: 2165957
- Cancer Res Treat.
- 2010 Dec;42(4):235-238.
Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare form of primary liver cancer composed of cells with histopathologic features of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Because of its low incidence,... -
- CITED
-
- Close
- SHARE
-
- Close
- Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13)
-
Koo DH, Jung M, Kim YH, Jeung HC, Zang DY, Bae WK, Kim H, Kim HS, Lee Ck, Kwon WS, Chung HC, Rha SY
- KMID: 2560248
- Cancer Res Treat.
- 2024 Oct;56(4):1136-1145.
- doi: 10.4143/crt.2023.1324
Purpose Varlitinib is a pan-human epidermal growth factor receptor (HER) inhibitor targeting epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and HER4. We present a phase... -
- CITED
-
- Close
- SHARE
-
- Close
- The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients
-
Lee Ck, Chon HJ, Kwon WS, Ban HJ, Kim SC, Kim H, Jeung HC, Chung J, Rha SY
- KMID: 2535364
- Genomics Inform.
- 2022 Sep;20(3):e29.
- doi: 10.5808/gi.22051
Several studies have shown associations between irinotecan toxicity and UGT1A genetic variations in colorectal and lung cancer, but only limited data are available for gastric cancer patients. We evaluated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
-
Park HS, Lee HS, Park JS, Park JS, Lee DK, Lee SJ, Yoon DS, Lee MG, Jeung HC
- KMID: 2356227
- Cancer Res Treat.
- 2016 Oct;48(4):1253-1263.
- doi: 10.4143/crt.2015.400
PURPOSE: This study focused on implementation of a prognostic scoring index based on clinico-laboratory parameters measured routinely on admission in metastatic pancreatic cancer patients. MATERIALS AND METHODS: Records from 403 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Wernicke's Encephalopathy in Advanced Gastric Cancer
-
Jung ES, Kwon O, Lee SH, Lee KB, Kim JH, Yoon SH, Kim GM, Jeung HC, Rha SY
- KMID: 2165962
- Cancer Res Treat.
- 2010 Jun;42(2):77-81.
PURPOSE: With their prolonged survival and malnutrition, cancer patients, and especially gastrointestinal (GI) tract cancer patients, can develop Wernicke's encephalopathy (WE). The aim of this study is to remind physicians... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer
-
Park HS, Park JS, Chun YJ, Roh YH, Moon J, Chon HJ, Choi HJ, Park JS, Lee DK, Lee SJ, Yoon DS, Jeung HC
- KMID: 2394831
- Cancer Res Treat.
- 2017 Oct;49(4):1127-1139.
- doi: 10.4143/crt.2016.538
PURPOSE: Metastatic biliary tract cancer (mBTC) has a dismal prognosis. In this study, an independent dataset of patients with mBTC was used to implement and validate a routine clinico-laboratory parameter-based... -
- CITED
-
- Close
- SHARE
-
- Close
